Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| L-Threoninamide | Cas No. 49705-99-9. Molecular formula: C4H10N2O2. Mole weight: 118.1. |  |
| L-Threoninamide,d-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-arginyl-L-threonyl-3-mercapto-L-valyl-,cyclic(2®7)-disulfide | Heterocyclic Organic Compound. CAS No. 103429-32-9. Molecular formula: C51H69N13O11S2. Mole weight: 1104.3. Catalog: ACM103429329. |  |
| L-Threoninamide,d-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-ornithyl-L-threonyl-3-mercapto-L-valyl-,cyclic(2®7)-disulfide | Heterocyclic Organic Compound. CAS No. 103429-31-8. Molecular formula: C50H67N11O11S2. Mole weight: 1062.26. Purity: >95 %. Catalog: ACM103429318. | |
| L-Threoninamide,glycyl-L-tryptophyl-L-threonyl-L-Leucyl-L-asparaginyl-L-seryl-L-alanylglycyl-L-tyrosyl-L-Leucyl-L-Leucylglycyl-L-prolyl-L-histidyl-L-alanyl-L-isoleucyl-l-a-aspartyl-l-asparaginyl-l-his | Heterocyclic Organic Compound. Alternative Names: GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2; GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-PRO-HIS-ALA-ILE-ASP-ASN-HIS-ARG-SER-PHE-SER-ASP-LYS-HIS-GLY-LEU-THR-NH2; Rat galanin; H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-. CAS No. 114547-31-8. Molecular formula: C141H211N43O41. Mole weight: 3164.45. Appearance: White lyophilized powder. Purity: 0.96. IUPACName: Galanin (1-29) (rat, mouse). Canonical SMILES: CCC (C)C (C (=O)NC (CC (=O)O)C (=O)NC (CC (=O)N)C (=O)NC (CC1=CNC=N1)C (=O)NC (CCCNC (=N)N)C (=O)NC (CO)C (=O)NC (CC2=CC=CC=C2)C (=O)NC (CO)C (=O)NC (CC (=O)O)C (=O)NC (CCCCN)C (=O)NC (CC3=CNC=N3)C (=O)NCC (=O)NC (CC (C)C)C (=O)NC (C (C)O)C (=O)N)NC (=O)C (C)NC (=O)C (CC4=CNC=N4)NC (=O)C5CCCN5C (=O)CNC (=O)C (CC (C)C)NC (=O)C (CC (C)C)NC (=O)C (CC6=CC=C (C=C6)O)NC (=O)CNC (=O)C (C)NC (=O)C (CO)NC (=O)C (CC (=O)N)NC (=O)C (CC (C)C)NC (=O)C (C (C)O)NC (=O)C (CC7=CNC8=CC=CC=C87)NC (=O)CN. Catalog: ACM114547318. | |
| Epoxomicin (BU-4061T, N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N- [ (1S) -3-methyl-1 [ [ (2R) -2-methyloxiranyl] carbonyl] butyl] -L-threoninamide) | Originally isolated from Actinomycetes strain based on its potent in vivo antitumor activity, Epoxomicin is a potent, cell-permeable, selective and irreversible proteasome inhibitor. More potent inhibitor of the chymotrypsin-like activity of the proteasome than Lactacystin. Blocks also trypsin-like and PGPH activities of the proteasome. Group: Biochemicals. Grades: Highly Purified. CAS No. 134381-21-8. Pack Sizes: 50ug, 250ug. US Biological Life Sciences. |  Worldwide |
| Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-aldehyde | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-aldehyde, a potent and reversible caspase-8 inhibitor, enables cell permeability by linking to a nonpolar CPP corresponding to the Kaposi fibroblast growth factor (FGF) signaling peptide sequence. Synonyms: Caspase-8 Inhibitor I, Cell Permeable; N-Acetyl-L-alanyl-L-alanyl-L-valyl-L-alanyl-L-leucyl-L-leucyl-L-prolyl-L-alanyl-L-valyl-L-leucyl-L-leucyl-L-alanyl-L-leucyl-L-leucyl-L-alanyl-L-prolyl-L-isoleucyl-L-α-glutamyl-N-[(2S)-1-carboxy-3-oxo-2-propanyl]-L-threoninamide; N-Acetyl-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-al; L-Threoninamide, N-acetyl-L-alanyl-L-alanyl-L-valyl-L-alanyl-L-leucyl-L-leucyl-L-prolyl-L-alanyl-L-valyl-L-leucyl-L-leucyl-L-alanyl-L-leucyl-L-leucyl-L-alanyl-L-prolyl-L-isoleucyl-L-α-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-. Grades: ≥95%. CAS No. 886462-83-5. Molecular formula: C95H162N20O26. Mole weight: 2000.42. | |
| Ac-Ser-Ile-Tyr-Val-Ala-Thr-NH2 | Synonyms: Ac-L-Ser-L-Ile-L-Tyr-L-Val-L-Ala-L-Thr-NH2; acetyl-SIYVAT-NH2; N-acetyl-L-seryl-L-isoleucyl-L-tyrosyl-L-valyl-L-alanyl-L-threoninamide; (2S,3S)-2-((S)-2-acetamido-3-hydroxypropanamido)-N-((S)-1-(((S)-1-(((S)-1-(((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)-3-methylpentanamide; L-Threoninamide, N-acetyl-L-seryl-L-isoleucyl-L-tyrosyl-L-valyl-L-alanyl-. CAS No. 1401804-68-9. Molecular formula: C32H51N7O10. Mole weight: 693.80. | |
| Ac-Ser-Val-Val-Val-Arg-Thr-NH2 | Synonyms: (S)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-5-guanidino-2-((2S,5S,8S,11S)-11-(hydroxymethyl)-2,5,8-triisopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecanamido)pentanamide; Ac-L-Ser-L-Val-L-Val-L-Val-L-Arg-L-Thr-NH2; acetyl-SVVVRT-NH2; N-acetyl-L-seryl-L-valyl-L-valyl-L-valyl-L-arginyl-L-threoninamide; L-Threoninamide, N-acetyl-L-seryl-L-valyl-L-valyl-L-valyl-L-arginyl-. CAS No. 1401804-69-0. Molecular formula: C30H56N10O9. Mole weight: 700.84. | |
| Autoinducing Peptide I | Autoinducing Peptide I is an autoinducing peptide (AIP) that activates the agr (accessory gene regulator) site to control the expression of extracellular proteins in S. aureus. Synonyms: AIP1; H-Tyr-Ser-Thr-cyclo(-Cys-Asp-Phe-Ile-Met); L-Methionine, L-tyrosyl-L-seryl-L-threonyl-L-cysteinyl-L-α-aspartyl-L-phenylalanyl-L-isoleucyl-, (8?4)-thiolactone; L-Tyrosyl-L-seryl-N-{(3S,6S,9S,12S,15R)-9-benzyl-6-[(2S)-2-butanyl]-12-(carboxymethyl)-3-[2-(methylsulfanyl)ethyl]-2,5,8,11,14-pentaoxo-1-thia-4,7,10,13-tetraazacyclohexadecan-15-yl}-L-threoninamide. Grades: ≥95%. CAS No. 200010-29-3. Molecular formula: C43H60N8O13S2. Mole weight: 961.11. | |
| Epoxomicin | Antibiotic. Potent anticancer compound. Cell permeable, potent, selective and irreversible 20S proteasome inhibitor. Predominantly inhibits the chymotrypsin-like (CTRL) activity of the proteasome. Exhibits lower level inhibition of proteasome trypsin-like and caspase-like activitives (100 and 1,000-fold slower rates respectively). Anti-inflammatory. Antimicrobial and antimalarial. Anti-parasitic. Stimulates bone formation by inhibiting osteoblast proteasome activity. Induces Parkinson's-like symptoms in rats. The ubiquitin-proteasome system (UPS) and autophagy serve as two complementary, reciprocally regulated protein degradation systems. Blockade of UPS by Epoxomicin activates autophagy. Group: Biochemicals. Alternative Names: N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N- [ (1S) -3-methyl-1- [ [ (2R) -2-methyloxiranyl] carbonyl] butyl] -L-threoninamide, BU 4061T. Grades: Highly Purified. CAS No. 134381-21-8. Pack Sizes: 50ug, 100ug, 250ug, 500ug. Molecular Formula: C??H??N?O?, Molecular Weight: 554.7. US Biological Life Sciences. | Worldwide |
| Lanreotide | Laromustine is a sulfonyl hydrazine prodrug with antineoplastic activity. Laromustine releases the DNA chloroethylating agent 90CE after entering the blood stream; 90CE chloroethylates alkylates the 06 position of guanine, resulting in DNA crosslinking, strand breaks, chromosomal aberrations, and disruption of DNA synthesis. Intracellular metabolism of this agent also releases methyl isocyanate which inhibits 06-alkyl-guanine transferase, an enzyme involved with DNA repair. Synonyms: Angiopeptin; Autogel; BIM 23014; DC 13-116; Dermopeptin; Ipstyl; L-Autogel; Lanreotide Autogel; Somatulin; Somatulin-Autogel; Somatuline Depot; L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2?7)-disulfide; H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2; 3-(2-naphthyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide (2->7)-disulfide. Grades: 98%. CAS No. 108736-35-2. Molecular formula: C54H69N11O10S2. Mole weight: 1096.33. | |
| Lanreotide Acetate | Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma. Group: Biochemicals. Alternative Names: 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2?7)-disulfide L-Threoninamide Acetate; 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv. Acetate; 2: PN: WO0006185 PAGE: 8 claimed protein Acetate; BIM 23014C Acetate; Somatulina Acetate; Somatuline Acetate. Grades: Highly Purified. CAS No. 127984-74-1. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| L-Threonine amide hydrochloride | L-Threonine Amide Hydrochloride is used as a reagent in the synthesis of N-monosubstituted [(pyridin-2-yl)methyl]amine and [(pyrimidin-4-yl)methyl]amine derivatives as transient receptor potential cation channel 3 (TRPV3) modulators. Synonyms: L-Thr-NH2 HCl; H-Thr-NH2 HCl; 2-Amino-3-hydroxy-(2S,3R)butanamide monohydrochloride; L-Threoninamide hydrochloride. Grades: ≥ 98%(HPLC). CAS No. 33209-01-7. Molecular formula: C4H10N2O2·HCl. Mole weight: 154.60. | |
| N-Ac-Lanreotide | N-Ac-Lanreotide is an impurity of Lanreotide, which is a somatostatin analogue with antineoplastic activity. Synonyms: Ac-D-2-naphthylalanyl-L-cystyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cystyl-Threoninamide (Disulfide bridge between cysteines); Lanreotide Impurity H; DC-13-155; L-Threoninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2?7)-disulfide. CAS No. 109605-17-6. Molecular formula: C56H71N11O11S2. Mole weight: 1138.37. | |
| TMC-89A | TMC-89A is a 20S proteasome inhibitor produced by streptomyces sp. TC 1087. It inhibited chymotrypsin-like (ChT-L), trypsin-like (T-L), and peptidylglutamyl-peptide hydrolyzing (PGPH) activities of 20S proteasome with IC50 of 1.1, 0.39 and 7.2 μmol/L, respectively. Synonyms: TMC-89 A; N-[(2R)-3-amino-2-methyl-3-oxopropanoyl]-L-threonyl-N-{1-[2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl}-L-threoninamide. Molecular formula: C21H36N4O9. Mole weight: 488.5. | |
| TMC-89B | TMC-89B is a 20S proteasome inhibitor produced by streptomyces sp. TC 1087. It inhibited chymotrypsin-like (ChT-L), trypsin-like (T-L), and peptidylglutamyl-peptide hydrolyzing (PGPH) activities of 20S proteasome with IC50 of 1.1, 0.51 and 7.1 μmol/L, respectively. Synonyms: TMC-89 B; N-[(2S)-3-amino-2-methyl-3-oxopropanoyl]-L-threonyl-N-{1-[2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl}-L-threoninamide. Molecular formula: C21H36N4O9. Mole weight: 488.5. | |
| YM-47141 | YM-47141 is a cyclic-depsipeptide produced by Flexibacter sp. Q17897. It acts as an elastase inhibitor with IC50 of 1.5 X 10(-7) mol/L. Synonyms: YM 47141; N-(phenylacetyl)-L-phenylalanyl-N-[(3R,6S,9S,14S,17S,18R)-6-(2-amino-2-oxoethyl)-3,18-dimethyl-9,14-bis(2-methylpropyl)-2,5,8,11,12,13,16-heptaoxo-1-oxa-4,7,10,15-tetraazacyclooctadecan-17-yl]-L-threoninamide. Molecular formula: C46H62N8O13. Mole weight: 935. | |
| YM-47142 | YM-47142 is a cyclic-depsipeptide produced by Flexibacter sp. Q17897. It acts as an elastase inhibitor with IC50 of 3.0 X 10(-7) mol/L. Synonyms: YM 47142; N-(3-methylbutanoyl)-L-phenylalanyl-N-[(3R,6S,9S,14S,17S,18R)-6-(2-amino-2-oxoethyl)-3,18-dimethyl-9,14-bis(2-methylpropyl)-2,5,8,11,12,13,16-heptaoxo-1-oxa-4,7,10,15-tetraazacyclooctadecan-17-yl]-L-threoninamide. Molecular formula: C43H64N8O13. Mole weight: 901. | |
Our database is helping our users find suppliers everyday.
